Clinical trials in Wroclaw – page 56

951 clinical trials in Wroclaw, Poland across 13 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PolandBadaniaKliniczne.pl

Wroclaw at a glance

951

clinical trials

Research sites13

Quick filters

951 trials in Wroclaw

Open in trial search

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Stemline Therapeutics Inc.

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Study of alectinib, pemetrexed, carboplatin and cisplatin in patients with resectable stage I-III non-small cell lung cancer

Registered drugNo placebo

Study of alectinib, pemetrexed, carboplatin and cisplatin in patients with resectable stage I-III non-small cell lung cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Alectinib
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Hypertrophic cardiomyopathy

Not recruiting

Study on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy

Registered drug

Study on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Sotagliflozin
Sponsor:Lexicon Pharmaceuticals Inc.

Contact Research Centre

Atrial fibrillation+5

Not recruiting

Study of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome

Registered drug

Study of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Allopurinol
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Hidradenitis

Not recruiting

Study on the Effectiveness and Safety of Brensocatib for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Study on the Effectiveness and Safety of Brensocatib for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Brensocatib
Sponsor:Insmed Inc.

Contact Research Centre

Migraine

Not recruiting

Study on Atogepant for Preventing Menstrual Migraine in Women

Investigational

Study on Atogepant for Preventing Menstrual Migraine in Women

Investigational

Poland

Participants:18–64 years
Substances:Atogepant
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

Registered drugNo placebo

Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:RO7284755
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Hidradenitis+1

Not recruiting

Study on the Safety of INF904 for Patients with Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

InvestigationalNo placebo

Study on the Safety of INF904 for Patients with Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:INF904
Sponsor:InflaRx GmbH

Contact Research Centre

Transitional cell carcinoma+1

Not recruiting

Study of Livmoniplimab and Budigalimab Compared to Chemotherapy for Adults with Advanced Bladder Cancer

Registered drugNo placebo

Study of Livmoniplimab and Budigalimab Compared to Chemotherapy for Adults with Advanced Bladder Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Budigalimab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

HIV infection

Not recruiting

Study Comparing Weekly Islatravir/Lenacapavir Regimen to Standard Care in HIV Patients with Controlled Viral Load

Registered drugNo placebo

Study Comparing Weekly Islatravir/Lenacapavir Regimen to Standard Care in HIV Patients with Controlled Viral Load

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Abacavir
Sponsor:Gilead Sciences Inc.

Contact Research Centre

Hidradenitis

Not recruiting

Study on the Effectiveness of AVTX-009 for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

Investigational

Study on the Effectiveness of AVTX-009 for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:AVTX-009
Sponsor:Avalo Therapeutics Inc.

Contact Research Centre

Crohn's disease

Not recruiting

Study on the Safety and Effects of ORG-129 in Patients with Fibrostenotic Crohn's Disease

Investigational

Study on the Safety and Effects of ORG-129 in Patients with Fibrostenotic Crohn's Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:ORG-129
Sponsor:Agomab Spain S.L.U.

Contact Research Centre

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Wroclaw

What the registry says about research in the country

01 Respiratory Diseases

Innovative clinical trials focusing on respiratory viral infections, including studies of vaccines against RSV and human metapneumovirus in older adults. Research includes evaluation of novel immunization approaches for influenza prevention and lower respiratory tract infections.

RSV vaccine development
Influenza prevention
Respiratory infection management

02 Dermatological Conditions

Comprehensive research into plaque psoriasis and related conditions, examining new therapeutic approaches including biologics and oral medications. Studies focus on both moderate to severe cases and specific manifestations like genital psoriasis.

Psoriasis treatment innovations
Psoriatic arthritis therapies
Biological response modifiers

03 Autoimmune Disorders

Groundbreaking trials investigating treatments for various autoimmune conditions, including Sjögren's disease and systemic sclerosis. Research focuses on novel therapeutic approaches and long-term disease management strategies.

Innovative antibody treatments
Disease-modifying therapies
Immunological interventions

Back to Poland All countries